A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia

Study Identifier
191622-066
CT.gov Identifier
NCT00168441
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Neuroscience - Other
    • Study Drug
  • Botulinum Toxin Type A
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Postherpetic neuralgia for more than 3 months after the healing of a herpes zoster skin rash.
    Exclusion Criteria:
    * Previous use of botulinum toxin of any serotype or immunization to any botulinum toxin serotype.

    Protocol Summary

    4-month study including a 30-day baseline phase

    Study Locations

    No locations found.